HNL Lab Medicine Executive and Leadership Team

Matthew Sorrentino, the Chief Executive Officer at HNL Lab Medicine, directs the overarching strategic vision and operational framework for the organization. Sorrentino guides the company's expansion initiatives and ensures alignment with market demands for advanced diagnostic services. This leadership role involves fostering innovation in laboratory technology and service delivery to maintain HNL Lab Medicine's position as a premier provider. By focusing on sustainable growth and operational efficiency, Matthew Sorrentino drives the company's mission to deliver high-quality testing and diagnostic solutions to healthcare providers and clients throughout Pennsylvania and New Jersey. The Chief Executive Officer's purview encompasses all facets of the business, from clinical operations to client relations, ensuring a cohesive and effective organizational strategy.

Martin Till, the President & Chief Executive Officer at HNL Lab Medicine, spearheads the company's strategic direction and executive leadership. Till oversees all major business operations, ensuring the delivery of comprehensive laboratory services across its extensive network. This role involves cultivating key relationships with healthcare institutions and industrial clients, driving growth through innovative diagnostic solutions. By championing operational excellence, Martin Till ensures HNL Lab Medicine consistently meets the evolving needs of patients and providers throughout Pennsylvania and New Jersey. The President & Chief Executive Officer's responsibilities include guiding financial performance, enhancing service offerings, and maintaining the organization's reputation for quality and reliability in clinical and anatomic pathology.

David Beckwith, the President & Chief Executive Officer at HNL Lab Medicine, sets the strategic course and executive vision for the organization. Beckwith leads the company's commitment to providing comprehensive diagnostic testing and laboratory services across its operational footprint. This executive position involves driving market penetration and ensuring the highest standards of clinical accuracy and patient care. By focusing on technological advancement and service optimization, David Beckwith reinforces HNL Lab Medicine's role as a critical partner for physicians, hospitals, and employers. The President & Chief Executive Officer's mandate includes fostering a culture of excellence and ensuring the organization's continued success in delivering essential health information to a broad patient population.

David Confalone, the Chief Financial Officer at HNL Lab Medicine, manages the organization's financial health and strategic fiscal planning. Confalone oversees all financial operations, including budgeting, forecasting, and resource allocation, ensuring robust financial stability. This critical role involves developing financial strategies that support HNL Lab Medicine's growth objectives and operational expansion throughout Pennsylvania and New Jersey. By maintaining stringent financial controls and identifying investment opportunities, David Confalone directly contributes to the company's capacity to deliver advanced diagnostic services. The Chief Financial Officer's expertise is essential for navigating the complex financial landscape of the healthcare sector and optimizing profitability.

Warren Erdmann, the Chief Operating Officer at HNL Lab Medicine, oversees the day-to-day operational execution and efficiency of the organization's laboratory services. Erdmann manages the complex logistical network that supports multiple locations throughout Pennsylvania and New Jersey, ensuring seamless delivery of testing and diagnostic solutions. This role involves optimizing laboratory workflows, implementing quality control measures, and enhancing service delivery to physician offices, hospitals, and industrial clients. By focusing on operational excellence and resource management, Warren Erdmann ensures HNL Lab Medicine maintains its capacity to produce extensive clinical and anatomic pathology results accurately and promptly. The Chief Operating Officer's leadership is fundamental to the organization's ability to meet diverse medical and organizational needs.

Jessica Bargilione, the Chief Marketing Officer at HNL Lab Medicine, directs the company's market presence and strategic brand development. Bargilione oversees all marketing initiatives, including client outreach, service promotion, and market analysis, to enhance HNL Lab Medicine's visibility and client engagement. This leadership position focuses on communicating the value of comprehensive laboratory services to physician offices, hospitals, and industrial clients across the region. By crafting targeted marketing campaigns and strengthening client relationships, Jessica Bargilione drives demand for the organization's extensive clinical and anatomic pathology testing. The Chief Marketing Officer's efforts are crucial for expanding the company's reach and solidifying its reputation as a leading diagnostic provider.

Angela Connell, the Chief Administrative Officer at HNL Lab Medicine, directs the comprehensive administrative functions that support the organization's operational and strategic objectives. Connell oversees critical areas such as human resources, regulatory compliance, and internal policy development, ensuring efficient and effective business practices. This leadership role is vital for maintaining the organizational infrastructure necessary to support extensive laboratory services across Pennsylvania and New Jersey. By fostering a productive work environment and ensuring adherence to industry standards, Angela Connell contributes significantly to HNL Lab Medicine's ability to serve its broad client base. The Chief Administrative Officer's purview ensures that all administrative processes align with the company's mission of delivering high-quality diagnostic solutions.